CD63 as a potential biomarker for patients with ovarian cancer. Nakamura K, Ida N, Hirasawa A, Okamoto K, et al. Eur J Obstet Gynecol Reprod Biol 2025;306:87-93.

Read + Share

Amedeo Smart

Independent Medical Education

Nakamura K, Ida N, Hirasawa A, Okamoto K, et al. CD63 as a potential biomarker for patients with ovarian cancer. Eur J Obstet Gynecol Reprod Biol 2025;306:87-93.
PMID: 39799740